Feb 22, 2026 by Matt DiLalloThis Elite 5.5%-Yielding Dividend Stock Continues to Fill Up Its Growth EngineEnbridge has lots of growth coming down the pipeline.
Feb 22, 2026 by Jonathan PoncianoVistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture BetVistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide.
Feb 22, 2026 by Jonathan PoncianoArray Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue GrowthArray Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide.
Feb 22, 2026 by Jonathan PoncianoEnviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This PortfolioEnviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products.
Feb 22, 2026 by Prosper Junior BakinyMerck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for DecadesThe company might bend, but it won't break.
Feb 22, 2026 by Adé HennisUrban Outfitters CCO Sells 18,666 Shares for $1.3 MillionThe Hayne family have been on a selling spree the last few months, but these transactions typically have one thing in common.
Feb 22, 2026 by Jonathan PoncianoInteger Stock Down 38%, but One Fund Just Bet $40 Million on a TurnaroundInteger Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.
Feb 22, 2026 by Neil PatelThe Best Stocks to Invest $50,000 in Right NowInvestors don't have to look any further than these two dominant internet firms.
Feb 22, 2026 by Robert IzquierdoIs Cognex Stock a Buy or Sell After a Director Dumped Shares Worth $128,000?This automation technology leader, known for machine vision systems, reported a notable insider sale amid strong one-year share performance.
Feb 22, 2026 by Maurie BackmanCounting on Home Equity to Fund Your Retirement? Here's Why You Shouldn't.It might seem like a good plan, but it could backfire.
Feb 22, 2026 by Brett SchaferWhere Will Rocket Lab Stock Be in 10 Years?The spaceflight company has shot up like, well, a rocket since its market debut a few years ago.
Feb 22, 2026 by Daniel FoelberPrediction: 3 Stocks That'll Be Worth More Than Walmart 5 Years From NowWalmart has crushed the S&P 500 in recent years, but the red-hot stock is due for a cooldown.
Feb 22, 2026 by Reuben Gregg BrewerNovartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for DecadesNovartis has a solid portfolio of drugs and a pipeline that should keep the business humming.
Feb 22, 2026 by Robert IzquierdoJFrog's CTO Sold Shares Worth $2.5 Million. Is the Stock a Buy or Sell?JFrog, a leader in DevOps software solutions, reported a notable insider sale amid ongoing growth in enterprise adoption.
Feb 22, 2026 by Daniel SparksIs CrowdStrike Stock a Buy After Falling 17% Year to Date?CrowdStrike is still growing quickly, but the stock's valuation assumes that pace holds up with little noise.
Feb 22, 2026 by Todd ShriberBetting Against Wall Street: The Inverse ETF Surge No One Is Talking AboutThe ProShares UltraShort Financials ETF ratchets up bearish bets on a popular sector.
Feb 22, 2026 by Micah Zimmerman2 Quantum Computing Stocks That Could Make a MillionaireQuantum computing is still a high-risk frontier, but for patient investors, these two tickers could be tomorrow's generational wealth creators.
Feb 22, 2026 by Jonathan PoncianoPraxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 MillionPraxis Precision Medicines targets neurological and psychiatric disorders with a pipeline of precision therapies for CNS conditions.
Feb 22, 2026 by Jonathan PoncianoCelcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two PositionCelcuity develops targeted cancer therapies and diagnostic platforms, with a focus on advancing precision medicine in oncology.
Feb 22, 2026 by Dave Kovaleski2 Financial Stocks Poised for a Comeback in 2026Both stocks are in the Berkshire Hathaway portfolio, selected by former CEO Warren Buffett.
